Joincare Pharmaceutical
Joincare Pharmaceutical Group Industry Co., Ltd., commonly known as Joincare, is a prominent player in the pharmaceutical sector, headquartered in China (CN). Established in 1992, the company has made significant strides in the industry, focusing on research and development, manufacturing, and distribution of a diverse range of pharmaceutical products. With a strong presence in major operational regions across Asia and beyond, Joincare is renowned for its innovative formulations and high-quality generics. The company’s core offerings include prescription medications, over-the-counter drugs, and health supplements, distinguished by their efficacy and safety. Joincare has achieved notable market recognition, positioning itself as a leader in the pharmaceutical landscape, driven by a commitment to advancing healthcare solutions.
DitchCarbon Score
How does Joincare Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Joincare Pharmaceutical's score of 27 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Joincare Pharmaceutical's reported carbon emissions
In 2023, Joincare Pharmaceutical reported total carbon emissions of approximately 514,332,930 kg CO2e. This figure includes 155,807,280 kg CO2e from Scope 1 emissions, 358,525,650 kg CO2e from Scope 2 emissions, and 1,033,000,900 kg CO2e from Scope 3 emissions. Over the previous years, the company has shown a trend in its emissions data. In 2022, total emissions were about 565,660,000 kg CO2e, with Scope 1 and 2 emissions at approximately 1,037,613,500 kg CO2e. In 2021, total emissions reached around 535,831,500 kg CO2e, with Scope 1 and 2 emissions totalling about 1,005,579,800 kg CO2e. The data indicates a reduction in total emissions from 2022 to 2023. Despite these figures, Joincare Pharmaceutical has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests that while the company is tracking its emissions, it may not yet have formalised a comprehensive strategy for significant emissions reductions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 35,758,600 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,044,456,800 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Joincare Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
